Tag Archives: TRIPS

IP negotiations at the UN High-Level Meeting on HIV/AIDS

UN High Level Meeting on HIV/AIDS is set to take place from 8–10 June 2011 in New York to review progress and chart the future course of the global AIDS response. Member States are expected to adopt a new Declaration … Continue reading

Posted in HIV/Aids, TRIPS, TRIPS plus, UN General Assembly HLM | Tagged , , , , , , , , | 4 Comments

Press: EU’s pharma trade hoax

Source: The Hindu Business Line, 25.2.2011, by Tahir Amin/Priti Radhakrishnan The proposed India-EU trade pact is riddled with intellectual property provisions that would harm India’s 2005 Patent Act. Last month, the global health community cheered when India’s patent office ruled … Continue reading

Posted in EU-India FTA | Tagged , , , , , , | Leave a comment

Blog: India and Europe Trading Away Access to Medicines

Source: Open Society Foundation Blog Recent news reports <http://www.indianexpress.com/news/dont-swallow-this-pill/742546/0>  on negotiations between India and the European Union on a proposed free trade agreement (FTA) have many health and human rights experts worried that millions of people may be left without … Continue reading

Posted in EU-India FTA | Tagged , , , , | Leave a comment

Press: IPA concerned over PMO’s efforts to destabilize India’s IPR regime at the behest of EU

Source: Pharmabiz, 27.1.2011, by Ramesh Shankar The Indian Pharmaceutical Alliance (IPA), an association of leading Indian pharma companies, has raised alarm over the recent media reports that efforts are going on in the Prime Ministers Office (PMO) to destabilize India’s … Continue reading

Posted in EU-India FTA | Tagged , , , , , | Leave a comment

DNP+ letter to WHO on impact study on IP provisions in the India-EU FTA

WHO’s impact study on IP provisions in the India-EU FTA Dear Dr. Plianbangchang, I am writing on behalf of the Delhi Network of Positive People (DNP+). Our organization was founded in 1999 as a support group of people living with … Continue reading

Posted in EU-India FTA, Letters to officials | Tagged , , , , , , , | Leave a comment

Press: EU still pushing data exclusivity through FTA, India stands firm

Source: Pharmabiz, 22.1.2011, by Joseph Alexander European Union is still pushing India to accept TRIPS-plus data exclusivity provisions through the proposed Free Trade Agreement though India is still firmly against it, if the latest draft chapter on intellectual property rights … Continue reading

Posted in EU-India FTA | Tagged , , , | Leave a comment

Documents: Oxfam study on data exclusivity in the US-Jordan FTA

Oxfam briefing paper – All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines “The USA continues to impose TRIPS-plus rules on developing countries, thus preventing poor people from accessing inexpensive, generic medicines. … Continue reading

Posted in Uncategorized | Tagged , , , , | 1 Comment